Predicting subsquent significant hyperbilirubinemia in healthy term 在随后的显着预测健康足月高胆红素血症.docVIP

下载本文档

6
0
约1.73万字
约 19页
2018-06-19 发布于福建
举报
版权申诉

Predicting subsquent significant hyperbilirubinemia in healthy term 在随后的显着预测健康足月高胆红素血症.doc

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Predicting subsquent significant hyperbilirubinemia in healthy term 在随后的显着预测健康足月高胆红素血症

Model to Predict Hyperbilirubinemia in Healthy Term and Near-Term Newborns with Exclusive Breast Feeding Hsin-Chung Huang1,2, Hwai-I Yang3,4, Yu-Hsun Chang5, Rui-Jane Chang5, Mei-Huei Chen6, Chien-Yi Chen1, Hung-Chieh Chou1, Wu-Shiun Hsieh1, Po-Nien Tsao1 1Departments of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan 2Department of Pediatrics, Taipei City Hospital, Heping FuYou Branch, Taipei, Taiwan 3Molecular and Genomic Epidemiology Center, China Medical University Hospital, Taichung, Taiwan 4Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan 5Departemtn of Pediatrics, Buddhist Tzu Chi General Hospital, Hualien, Taiwan 6Department of Pediatrics, Cardinal Tien Hospital Yung Ho Branch, Taiwan Running title Model to predict significant neonatal hyperbilirubinemia Correspondence to: Dr. Po-Nien Tsao 1Departments of Pediatrics National Taiwan University Hospital, Taipei, Taiwan 8 Chung-Shan South Road, Taipei 10002, Taiwan Email: tsaopn@ntu.edu.tw Tel: 886-2ext 71551 Fax: 886-2Abstract Background: The aim of this study was to identify the high risk newborns who will subsequently develop significant hyperbilirubinemia during 4th to 10th days of life by using the clinical data from the first 3 days of life. Methods: We retrospectively collected exclusively breast-feeding healthy term and near-term newborns born in our nursery between May 1 2002 to June 30 2005. Clinical data, including serum bilirubin were collected and the significant predictors were identified. Bilirubin level≧15mg/dL during 4th to 10th days of life was defined as significant hyperbilirubinemia. A prediction model to predict subsequent hyperbilirubinemia was established. This model was externally validated in another group of newborns who enrolled by the same criteria to test its discrimination capability. Results: Totally, 1979 neonates were collected and 1208 cases were excluded by our exclusion criteria. Finally, 771 newb